http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201632192-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5da7f685e551ef644cdca4e75f5ca5f9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 |
| filingDate | 2015-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b992df9d4d247e6f065a7e674a9275 |
| publicationDate | 2016-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201632192-A |
| titleOfInvention | Influenza vaccine kit and method of use thereof |
| abstract | The invention relates to an influenza vaccine kit comprising: a first vaccine groupna composition comprising: an H1N1 influenza A virus, an H3N2 influenza A virus, and a first influenza B virus; and a second vaccine composition comprising: the first influenza B The virus is different from the second type B influenza virus. The present invention also provides a method of using the influenza vaccine kit described above, wherein the influenza vaccine kit is applied to a body and comprises the steps of: a. administering a first vaccine composition to the individual; and b. administering A second vaccine composition is administered to the individual about 1 to 10 days after the first vaccine composition. In this way, the prevention of influenza virus will be more effective and more extensive. |
| priorityDate | 2015-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.